Antag Therapeutics (private company)

Denmark
See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2BB2C (Retail)

Antag has developed a novel anti-obesity treatment based on a highly potent inhibitor of a hormone involved in fat accumulation.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.62M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Antag Therapeutics

Name Criteria
Denmark AFYX Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Draupnir Bio
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Fidabio
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Galecto Biotech
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Hoba Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark MedTrace
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Sweden Merozyne Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark MinervaX
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Muna Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Neurons
53%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • At least one vc investor: Vækstfonden

News about Antag Therapeutics


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top